Glaukos Gross Profit 2014-2024 | GKOS

Glaukos annual/quarterly gross profit history and growth rate from 2014 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Glaukos gross profit for the quarter ending June 30, 2024 was $0.073B, a 21.3% increase year-over-year.
  • Glaukos gross profit for the twelve months ending June 30, 2024 was $0.262B, a 16.47% increase year-over-year.
  • Glaukos annual gross profit for 2023 was $0.239B, a 11.81% increase from 2022.
  • Glaukos annual gross profit for 2022 was $0.214B, a 5.94% decline from 2021.
  • Glaukos annual gross profit for 2021 was $0.227B, a 70.66% increase from 2020.
Glaukos Annual Gross Profit
(Millions of US $)
2023 $239
2022 $214
2021 $227
2020 $133
2019 $198
2018 $156
2017 $138
2016 $98
2015 $59
2014 $34
2013 $18
Glaukos Quarterly Gross Profit
(Millions of US $)
2024-06-30 $73
2024-03-31 $65
2023-12-31 $63
2023-09-30 $60
2023-06-30 $60
2023-03-31 $56
2022-12-31 $54
2022-09-30 $54
2022-06-30 $55
2022-03-31 $51
2021-12-31 $56
2021-09-30 $59
2021-06-30 $60
2021-03-31 $51
2020-12-31 $54
2020-09-30 $47
2020-06-30 $10
2020-03-31 $23
2019-12-31 $50
2019-09-30 $51
2019-06-30 $51
2019-03-31 $47
2018-12-31 $47
2018-09-30 $38
2018-06-30 $37
2018-03-31 $34
2017-12-31 $37
2017-09-30 $35
2017-06-30 $36
2017-03-31 $31
2016-12-31 $28
2016-09-30 $26
2016-06-30 $24
2016-03-31 $20
2015-12-31 $17
2015-09-30 $16
2015-06-30 $14
2015-03-31 $12
2014-12-31 $9
2014-09-30 $10
2014-06-30 $9
2014-03-31 $6
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.197B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.667B 27.41
Intuitive Surgical (ISRG) United States $171.263B 96.97
Alcon (ALC) Switzerland $47.978B 33.77
IQVIA Holdings (IQV) United States $41.900B 23.74
Edwards Lifesciences (EW) United States $39.451B 25.29
IDEXX Laboratories (IDXX) United States $39.315B 47.29
DexCom (DXCM) United States $27.294B 38.92
STERIS (STE) Ireland $22.783B 26.58
SONOVA HOLDING (SONVY) Switzerland $21.950B 0.00
Waters (WAT) United States $20.926B 31.20
Hologic (HOLX) United States $18.638B 20.26
Sysmex ADR (SSMXY) Japan $12.525B 39.28
Fresenius Medical Care AG KGaA (FMS) Germany $12.147B 13.62
Teleflex (TFX) United States $11.269B 17.52
Globus Medical (GMED) United States $9.568B 26.77
Penumbra (PEN) United States $7.564B 78.52
Masimo (MASI) United States $7.385B 39.55
TransMedics (TMDX) United States $4.636B 198.53
Integer Holdings (ITGR) United States $4.329B 25.32
PROCEPT BioRobotics (PRCT) United States $3.773B 0.00
LivaNova (LIVN) United Kingdom $2.923B 17.14
Tandem Diabetes Care (TNDM) United States $2.735B 0.00
Nihon Kohden (NHNKY) Japan $2.599B 16.17
Elekta AB (EKTAY) Sweden $2.596B 21.15
Veracyte (VCYT) United States $2.523B 156.38
Inari Medical (NARI) United States $2.443B 0.00
RxSight (RXST) United States $1.809B 0.00
Integra LifeSciences Holdings (IART) United States $1.319B 6.01
Artivion (AORT) United States $1.108B 101.69
AVANOS MEDICAL, INC (AVNS) United States $1.066B 19.02
OPKO Health (OPK) United States $1.039B 0.00
Pulse Biosciences (PLSE) United States $0.979B 0.00
Alphatec Holdings (ATEC) United States $0.771B 0.00
Mesa Laboratories (MLAB) United States $0.723B 18.25
IRadimed (IRMD) United States $0.631B 34.12
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.612B 0.00
AxoGen (AXGN) United States $0.599B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.584B 0.00
Paragon 28 (FNA) United States $0.491B 0.00
Pacific Biosciences Of California (PACB) United States $0.469B 0.00
Tactile Systems Technology (TCMD) United States $0.343B 10.47
Treace Medical Concepts (TMCI) United States $0.332B 0.00
ClearPoint Neuro (CLPT) United States $0.309B 0.00
Sight Sciences (SGHT) United States $0.292B 0.00
AngioDynamics (ANGO) United States $0.248B 0.00
Delcath Systems (DCTH) United States $0.244B 0.00
Inogen (INGN) United States $0.216B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.192B 0.00
CVRx (CVRX) United States $0.191B 0.00
Nevro (NVRO) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.185B 0.00
Semler Scientific (SMLR) United States $0.175B 12.25
Alpha Tau Medical (DRTS) Israel $0.159B 0.00
908 Devices (MASS) United States $0.121B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.119B 0.00
Sensus Healthcare (SRTS) United States $0.103B 15.34
EDAP TMS S.A (EDAP) France $0.098B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
Envoy Medical (COCH) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.063B 0.00
LENSAR (LNSR) United States $0.052B 0.00
Accelerate Diagnostics (AXDX) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.044B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
T2 Biosystems (TTOO) United States $0.032B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Pixie Dust Technologies (PXDT) Japan $0.028B 0.00
Neuronetics (STIM) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Spectral AI (MDAI) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
PAVmed (PAVM) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00